Amoy Diagnostics Co Ltd
SZSE:300685

Watchlist Manager
Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd
SZSE:300685
Watchlist
Price: 24.8 CNY -4.62% Market Closed
Market Cap: 9.7B CNY
Have any thoughts about
Amoy Diagnostics Co Ltd?
Write Note

Relative Value

The Relative Value of one Amoy Diagnostics Co Ltd stock under the Base Case scenario is 37.59 CNY. Compared to the current market price of 24.8 CNY, Amoy Diagnostics Co Ltd is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
37.59 CNY
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
55
Median 3Y
10.8
Median 5Y
11.5
Industry
7.7
Forward
7.7
vs History
79
vs Industry
6
Median 3Y
39.1
Median 5Y
41.3
Industry
22.7
Forward
31.6
vs History
77
vs Industry
7
Median 3Y
58.6
Median 5Y
45.3
Industry
21.6
vs History
76
vs Industry
6
Median 3Y
70.8
Median 5Y
62.1
Industry
25.2
vs History
74
vs Industry
20
Median 3Y
6.4
Median 5Y
7.1
Industry
2.5
vs History
80
vs Industry
50
Median 3Y
10
Median 5Y
10.7
Industry
7.7
Forward
6.9
vs History
79
vs Industry
45
Median 3Y
12.1
Median 5Y
12.8
Industry
9
vs History
82
vs Industry
5
Median 3Y
45.3
Median 5Y
42.8
Industry
4.2
Forward
23.2
vs History
82
vs Industry
5
Median 3Y
45.3
Median 5Y
42.8
Industry
4.1
Forward
26.2
vs History
77
vs Industry
8
Median 3Y
54.6
Median 5Y
43.3
Industry
5.7
vs History
80
vs Industry
6
Median 3Y
95.6
Median 5Y
65.8
Industry
3.6
vs History
58
vs Industry
25
Median 3Y
10.3
Median 5Y
11.3
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Amoy Diagnostics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Amoy Diagnostics Co Ltd
SZSE:300685
9.9B CNY 8.3 31.4 26.1 26.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.6 -76.2
P/E Multiple
Earnings Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average P/E: 178.8
31.4
81%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average EV/EBITDA: 18.5
26.1
81%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.6 N/A
EV/EBIT Multiple
EBIT Growth
CN
Amoy Diagnostics Co Ltd
SZSE:300685
Average EV/EBIT: 23
26.1
75%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top